Cancer Research Center n.a. Blokhin, Chemotherapy Dept.

Moscow

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early